AXIM Biotechnologies, Inc. (AXIM) stock
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
AXIM Biotechnologies cash
Cash and short-term investments held at the end of each period.
AXIM Biotechnologies's cash was $6.04K at Jun 30, 2024. For fiscal 2023 it was $156.46K, up 230.9% from the year before. Over ten years it grew 103.7% a year on average. The highest annual figure on record is $2.06M in fiscal 2017.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $156.46K | +230.9% |
| FY2022 | Dec 31, 2022 | $47.28K | -89.6% |
| FY2021 | Dec 31, 2021 | $452.96K | -0.9% |
| FY2020 | Dec 31, 2020 | $457.18K | -10.6% |
| FY2019 | Dec 31, 2019 | $511.63K | -71.7% |
| FY2018 | Dec 31, 2018 | $1.81M | -12.3% |
| FY2017 | Dec 31, 2017 | $2.06M | +188.5% |
| FY2016 | Dec 31, 2016 | $713.35K | +431.7% |
| FY2015 | Dec 31, 2015 | $134.17K | -79.7% |
| FY2014 | Dec 31, 2014 | $661.13K | +520473.2% |
| FY2013 | Dec 31, 2013 | $127 | -99.3% |
| FY2012 | Dec 31, 2012 | $19.13K | -17.3% |
| FY2011 | Dec 31, 2011 | $23.14K | – |
| FY2010 | Dec 31, 2010 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | $6.04K | -93.8% |
| Q1 FY2024 | Mar 31, 2024 | $96.71K | +80.6% |
| Q4 FY2023 | Dec 31, 2023 | $156.46K | +230.9% |
| Q3 FY2023 | Sep 30, 2023 | $23.22K | -85.8% |
| Q2 FY2023 | Jun 30, 2023 | $97.50K | +49.6% |
| Q1 FY2023 | Mar 31, 2023 | $53.54K | -86.9% |
| Q4 FY2022 | Dec 31, 2022 | $47.28K | -89.6% |
| Q3 FY2022 | Sep 30, 2022 | $163.75K | -51.6% |
| Q2 FY2022 | Jun 30, 2022 | $65.16K | -67.8% |
| Q1 FY2022 | Mar 31, 2022 | $408.04K | -9.2% |
| Q4 FY2021 | Dec 31, 2021 | $452.96K | -0.9% |
| Q3 FY2021 | Sep 30, 2021 | $338.38K | -70.8% |
| Q2 FY2021 | Jun 30, 2021 | $202.19K | -77.3% |
| Q1 FY2021 | Mar 31, 2021 | $449.21K | +1.5% |
| Q4 FY2020 | Dec 31, 2020 | $457.18K | -10.6% |
| Q3 FY2020 | Sep 30, 2020 | $1.16M | -0.9% |
| Q2 FY2020 | Jun 30, 2020 | $891.43K | -59.6% |
| Q1 FY2020 | Mar 31, 2020 | $442.75K | -83.4% |
| Q4 FY2019 | Dec 31, 2019 | $511.63K | -71.7% |
| Q3 FY2019 | Sep 30, 2019 | $1.17M | +5737.1% |
| Q2 FY2019 | Jun 30, 2019 | $2.21M | +328.7% |
| Q1 FY2019 | Mar 31, 2019 | $2.66M | +266.9% |
| Q4 FY2018 | Dec 31, 2018 | $1.81M | -12.3% |
| Q3 FY2018 | Sep 30, 2018 | $20.00K | -99.4% |
| Q2 FY2018 | Jun 30, 2018 | $515.17K | -87.4% |
| Q1 FY2018 | Mar 31, 2018 | $725.59K | +14.7% |
| Q4 FY2017 | Dec 31, 2017 | $2.06M | +188.5% |
| Q3 FY2017 | Sep 30, 2017 | $3.08M | +253.9% |
| Q2 FY2017 | Jun 30, 2017 | $4.10M | +21949.3% |
| Q1 FY2017 | Mar 31, 2017 | $632.42K | +269.9% |
| Q4 FY2016 | Dec 31, 2016 | $713.35K | +431.7% |
| Q3 FY2016 | Sep 30, 2016 | $870.63K | +1912.6% |
| Q2 FY2016 | Jun 30, 2016 | $18.61K | -41.0% |
| Q1 FY2016 | Mar 31, 2016 | $170.97K | -12.4% |
| Q4 FY2015 | Dec 31, 2015 | $134.17K | -79.7% |
| Q3 FY2015 | Sep 30, 2015 | $43.26K | -95.4% |
| Q2 FY2015 | Jun 30, 2015 | $31.55K | – |
| Q1 FY2015 | Mar 31, 2015 | $195.25K | – |
| Q4 FY2014 | Dec 31, 2014 | $661.13K | – |
| Q3 FY2014 | Sep 30, 2014 | $949.81K | – |
See a number that looks wrong?